Infleqtion (INFQ) Wheel Strategy Research

Where Infleqtion trades right now

As of July 24, 2026, Infleqtion (INFQ) trades at $8.97, down roughly 37% year to date, near the bottom of its $8.52 to $21.28 range since going public. 100 shares cost about $895. It's an early-stage quantum-computing pure-play, which is exactly the kind of high-story, high-volatility name where the premium looks generous and the risk is very real.

The bull and bear case, honestly

Bull case: Infleqtion uses a neutral-atom quantum approach that can operate closer to room temperature than the near-absolute-zero setups superconducting systems need, potentially a lower barrier to data-center adoption. It reports a strong cash position (around $569 million, with little debt), a $100 million U.S. CHIPS Act award, and partnerships tied to national-security and research programs. Several analysts carry buy ratings with targets well above the current price.

Bear case: quantum is a winner-take-much race against deep-pocketed rivals, and there's no guarantee neutral-atom wins. Guided 2026 revenue is only around $40 million against a multi-billion valuation and ongoing losses, so the story depends on commercial contracts that haven't scaled yet. If they don't, the cash cushion erodes and dilution follows. The 37% year-to-date decline is the market already registering that uncertainty.

Support levels and a speculator's put strike

INFQ is trading near its post-IPO low, so it's essentially at support. Round-number reference levels are ~$9 (current) and ~$8 just below. For a small speculative position, a cash-secured put below the market would pay you to potentially buy lower, while accepting assignment into an unprofitable company that could keep sliding. Rather than pick the round number, the panel on this page reads the strike off the live chain at roughly 0.25 delta. The premium will look rich because the risk is; keep the size tiny, verify the live numbers, and model it with the wheel calculator.

Update, July 23: the numbers behind the story

Of the speculative names we follow, Infleqtion is the only one whose revenue is genuinely compounding, and that deserves to be shown rather than asserted.

Revenue rose 164% in FY2024 and has continued higher. Gross profit is positive and growing, so it sells above cost, which separates it from most of this list. And the loss stayed roughly flat while revenue tripled, which is the signature of real operating leverage rather than growth bought with proportional spending.

Why it has revenue when its peers do not

Infleqtion is not purely a quantum computing company, and this is the most under-discussed thing about it. The same atom-manipulation technology produces quantum sensors and atomic clocks, and unlike quantum computers, those already work and already sell.

• Atomic clocks precise enough to keep time when GPS is jammed or unavailable. That is a live defence requirement, not a future one.
• Quantum sensors that measure magnetic fields, gravity and radio signals far more precisely than conventional instruments, for navigation without satellites or detecting things underground.

A pure quantum-computing company sells nothing until the computers work. Infleqtion has a business selling clocks and sensors while the computing side develops.

July 2026: three DOE awards

On 22 July Infleqtion secured three separate projects under the U.S. Department of Energy's Genesis Mission, a roughly $5 billion federal initiative. Government research contracts matter disproportionately at this stage: they are non-dilutive, they validate the technology through expert technical review rather than a marketing claim, and they tend to lead to follow-on work.

The company also announced it will deploy a fault-tolerant neutral-atom quantum computer in Illinois. Fault tolerance is the industry's central unsolved problem, and an actual deployment is a different kind of claim from a roadmap slide.

The tell worth noticing

The three DOE awards were announced on 22 July. By the close on 23 July the stock traded at $8.97, below where it was before the announcement. Financial media separately reported investors selling the stock for nine consecutive sessions in mid-July.

When a stock cannot hold a gain on genuinely good news, that is information, and it usually means existing holders are looking for exits. The volume pattern underneath cuts the other way, though, and is worth weighing: the nine-day slide happened mostly on below-average volume, while the heavy-volume days were the up days. A decline nobody participates in is a different thing from one everybody participates in.

The defense thesis, and what the insiders did about it

The strongest version of the bull case is no longer about quantum computers. It is about sensing, and it is being written in Washington. In June the White House issued an executive order on quantum innovation, which Infleqtion publicly welcomed. The Department of War followed with an initiative to rebuild intelligence and reconnaissance around quantum sensing and a separate partnership to push Genesis Mission AI into defense work.

This matters for Infleqtion more than for the rest of the sector for a boring reason: the thing the Pentagon says it wants is the thing Infleqtion already sells. Atomic clocks and quantum inertial sensors let an aircraft or a ship keep accurate position and time when GPS is jammed or spoofed. That is a product with revenue behind it today, not a 2030 roadmap, and it is why this company has $33.6 million of trailing revenue while pure-play quantum computing peers have almost none.

The chip side is the same trade from the other end. Quantum processors cannot do useful work alone yet, so the practical architecture is hybrid: classical GPUs simulate quantum circuits before they run on real hardware, and they decode the flood of error data a live quantum machine produces fast enough to keep it stable. That makes NVIDIA and AMD the picks and shovels for quantum as well as for AI. AMD's chief executive projects the AI accelerator market compounding at 45% a year to $1.4 trillion by 2030. Treat that as a vendor forecast from the company selling the product, not as a neutral estimate, but the direction is corroborated by everyone building data centres.

So: real federal demand, a product that already exists, and a credible position in the supply chain. That is a genuine thesis, and it is the one being repeated everywhere right now.

Here is the part that is not being repeated. Over the twelve months to July 2026, Infleqtion insiders sold $232.6 million of stock on the open market and bought $3.0 million. That is not a ratio; it is a rout. The filings are public and the detail is in the table above.

The largest block, roughly $215 million, came from Maverick Capital and its affiliated director, who file the same disposals separately. Chief executive Matthew Kinsella sold $13.1 million himself on 22 and 26 May, at prices between $15.56 and $17.91. The chief technology officer, the chief revenue officer and another director sold in the same window. The stock is $8.97 now.

The Maverick connection is worth stating plainly, because it is not a coincidence of names. Kinsella spent roughly eighteen years at Maverick, was a managing director at its venture arm, and was Infleqtion's first investor in 2018 before taking the chief executive job in 2024. So the single largest seller is the fund he came from and whose investment he led, selling at the same time he did.

None of that is evidence of wrongdoing, and it is not proof the thesis is wrong. A SPAC lockup expiring produces exactly this pattern, a venture fund exists to return capital to its partners eventually, and a founder-investor turning nearly two decades of paper gains into money is ordinary behaviour rather than a signal. Insiders sell for reasons that have nothing to do with what a stock is worth.

But it does have to be weighed honestly, because the bull case above rests on the judgement of specific people, and in May those same people were sellers between $15 and $18. The market has since marked the stock to roughly half that. Anyone buying here is taking the other side of that trade, and should do it knowing whose side they are on.

What argues against it

• A $1.96 billion valuation on $33.6 million of revenue, roughly 58 times sales. Even accepting the growth and the government validation, a great deal of future success is already priced in.
• It loses $56 million a year and nothing in the current business suggests profitability is close.
• Quantum timelines slip, routinely, by years. It competes with IonQ, Quantinuum, Rigetti, D-Wave, Pasqal, IQM and the quantum divisions of Google, IBM and Microsoft. Being technically elegant does not guarantee commercial victory.
• Only 109 sessions of trading history since listing, all of it downward, so every statistical measure rests on a thin sample.
• It carried negative shareholders' equity of $183 million at the end of 2024, before it went public. The cash pile is recent and came from the listing, not from operations.
• At $8.97 it sits only 14% above its 52-week low of $8.52, so there is not much price history beneath it acting as support.

The practical constraint: capital

The cheapest sensible put strike here needs about $750 of collateral, roughly four times the commitment of the smallest names we cover. Open interest is decent, 1,667 contracts on the August $7.50 and 2,809 on the October, and the stock's 12-cent spread is tight. But implied volatility runs about 118% against 98% realised, a 20-point edge, which is thinner than it first appears. Quarterly results are expected around 13 August, inside the August expiry.